U.S. flag

An official website of the United States government

  • delete

NM_000492.4(CFTR):c.1052C>G (p.Thr351Ser) AND Inborn genetic diseases

Germline classification:
Uncertain significance (1 submission)
Last evaluated:
Sep 29, 2020
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001017142.2

Allele description

NM_000492.4(CFTR):c.1052C>G (p.Thr351Ser)

Gene:
CFTR:CF transmembrane conductance regulator [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
7q31.2
Genomic location:
Preferred name:
NM_000492.4(CFTR):c.1052C>G (p.Thr351Ser)
HGVS:
  • NC_000007.14:g.117540282C>G
  • NG_016465.4:g.79499C>G
  • NM_000492.4:c.1052C>GMANE SELECT
  • NP_000483.3:p.Thr351Ser
  • NP_000483.3:p.Thr351Ser
  • LRG_663t1:c.1052C>G
  • LRG_663:g.79499C>G
  • LRG_663p1:p.Thr351Ser
  • NC_000007.13:g.117180336C>G
  • NM_000492.3:c.1052C>G
  • NM_000492.4:c.1052C>G
  • P13569:p.Thr351Ser
Protein change:
T351S
Links:
UniProtKB: P13569#VAR_009899; dbSNP: rs1800086
NCBI 1000 Genomes Browser:
rs1800086
Molecular consequence:
  • NM_000492.4:c.1052C>G - missense variant - [Sequence Ontology: SO:0001583]
Functional consequence:
Normal function
Observations:
1

Condition(s)

Name:
Inborn genetic diseases
Identifiers:
MeSH: D030342; MedGen: C0950123

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV001178176Ambry Genetics
criteria provided, single submitter

(Ambry Autosomal Dominant and X-Linked criteria (7/2020))
Uncertain significance
(Sep 29, 2020)
germlineclinical testing

PubMed (2)
[See all records that cite these PMIDs]

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknown1not providednot provided1not providedclinical testing

Citations

PubMed

Cystic fibrosis transmembrane conductance regulator channel dysfunction in non-cystic fibrosis bronchiectasis.

Bienvenu T, Sermet-Gaudelus I, Burgel PR, Hubert D, Crestani B, Bassinet L, Dusser D, Fajac I.

Am J Respir Crit Care Med. 2010 May 15;181(10):1078-84. doi: 10.1164/rccm.200909-1434OC. Epub 2010 Feb 18.

PubMed [citation]
PMID:
20167849

Detection of more than 94% cystic fibrosis mutations in a sample of Belgian population and identification of four novel mutations.

Mercier B, Lissens W, Audrézet MP, Bonduelle M, Liebaers I, Ferec C.

Hum Mutat. 1993;2(1):16-20.

PubMed [citation]
PMID:
8477260

Details of each submission

From Ambry Genetics, SCV001178176.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided1not providednot providedclinical testing PubMed (2)

Description

The p.T351S variant (also known as c.1052C>G), located in coding exon 8 of the CFTR gene, results from a C to G substitution at nucleotide position 1052. The threonine at codon 351 is replaced by serine, an amino acid with similar properties. This variant has been reported in trans with a disease-causing mutation in an unaffected father of a cystic fibrosis patient (Mercier B et al. Hum. Mutat., 1993;2:16-20) as well as in an individual with diffuse bronchiectasis and normal sweat chloride levels (Bienvenu T et al. Am. J. Respir. Crit. Care Med., 2010 May;181:1078-84). This alteration was reported to be homozygous (and in cis with a second variant on both alleles) in a patient with a CFTR-related disorder (Trujillano et al. J Med Genet. 2013;50(7):455-62). Another study described this variant to be in cis with p.F508del in a patient with features of cystic fibrosis; a second disease causing alteration was not reported (Dal'Maso et al. J Bras Pneumol. 2013;39(2):181-9). This amino acid position is highly conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknown1not providednot provided1not providednot providednot provided

Last Updated: Nov 5, 2022